Lee's Pharmaceutical Holdings Ltd
HKEX:950
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
ISB Corp
TSE:9702
|
JP |
|
Bindal Exports Ltd
BSE:540148
|
IN |
Lee's Pharmaceutical Holdings Ltd
Inventory
Lee's Pharmaceutical Holdings Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lee's Pharmaceutical Holdings Ltd
HKEX:950
|
Inventory
HK$282.8m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
|
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Inventory
HK$1.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Inventory
¥2.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
11%
|
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Inventory
HK$43.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
H
|
HUTCHMED (China) Ltd
HKEX:13
|
Inventory
$41.1m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
|
Lee's Pharmaceutical Holdings Ltd
Glance View
Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacture and sale of pharmaceutical products. The firm operates through two segments. Proprietary Products segment is engaged in the manufacture and sales of self-developed pharmaceutical products. Its proprietary products include Yallaferon, Livaracine and Slounase, among others. Licensed-in Products segment is engaged in the trading of licensed-in pharmaceutical products. Its licensed-in products include Ferplex and Zanidip, among others. The Company’s products are for cardiovascular and infectious diseases, dermatology, oncology, gynecology and ophthalmology, among others. The firm mainly operates businesses in China and Hong Kong.
See Also
What is Lee's Pharmaceutical Holdings Ltd's Inventory?
Inventory
282.8m
HKD
Based on the financial report for Jun 30, 2025, Lee's Pharmaceutical Holdings Ltd's Inventory amounts to 282.8m HKD.
What is Lee's Pharmaceutical Holdings Ltd's Inventory growth rate?
Inventory CAGR 10Y
6%
Over the last year, the Inventory growth was 25%. The average annual Inventory growth rates for Lee's Pharmaceutical Holdings Ltd have been 3% over the past three years , -1% over the past five years , and 6% over the past ten years .
